DDW 2022 Tofacitinib, Vedolizumab Effective for UC Post-Anti-TNF Agent Failure Publish Date May 24, 2022 Researchers compared the effectiveness of tofacitinib and vedolizumab among patients with UC who had experienced anti-TNF failure.